Granules India Opens Two New Centres of Excellence at IITH

Granules India Limited unveiled the inauguration of two cutting-edge Centres of Excellence at the Technology Research Park of IIT Hyderabad.

These comprise the Ascelis Center of Excellence for Peptide Development and Characterization along with the Granules Center of Excellence for Particle Engineering. As of 12:37 PM, Granules India Limited's share price is up by 1.37% according to the latest news.

The inauguration was conducted by Dr. Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India, joined by Mrs. Uma Chigurupati, Executive Director of Granules India, and Professor B. S. Murty, Director of IIT Hyderabad.

Also Read: Sun Pharma Launches Ilumya in India for Severe PsoriasisThe Ascelis Center of Excellence for Peptide Development and Characterization has been created within Ascelis Peptides, which is the organization’s CDMO segment. This center will concentrate on creating cosmetic, therapeutic, and pharmaceutical peptides.

This is Ascelis’ first peptide development and characterization laboratory in India. Deeper scientific and technical capabilities are made possible by its ability to do primary, secondary, and tertiary structure characterisation.

The institute will also work closely with Senn Chemicals, the Swiss headquartered R&D unit of Granules. The cooperation boosts the company’s worldwide peptide development platform and lowers dependence on external partners by bringing sophisticated analytical and process development in-house.